Journal Collaborations & Media Partners
The Biomarkers Series UK marketing team work with leading journal publications on reciprocal marketing arrangements.
If you are interested in promoting your journal/association to the leading players in this industry please contact us.
www.bio-equip.com was established in the early days of the Internet, in July 1998. Over the last two decades, themed on "serving life sciences and serving high quality suppliers", Bio-equip has provided the users in the fields of life sciences, medicine research, biological pharmacy, bio-engineering, modern agriculture, food safety, environmental monitoring and forensic science with the industrial information in terms of devices and instruments, reagents, consumables, lab animals, cell lines, books, biological R&D service, second-hand instruments and instrument repairs. There are two versions, the Chinese version (bio-equip.com) and English version (bio-equip.cn): So far over 30,000 companies have registered as members and provided over 1 million product entries in the Chinese version (www.bio-equip.com), The daily visits exceed over 60,000.. The English version (www.bio-equip.cn), established in 2006, is the only English website in this field. Until August 2018, over 1,000 companies from both at home and abroad have registered as members, covering the fields of manufacturing, sale and agency of instruments/reagents with over 100,000 product entries.
PharmaVision offers a consultancy service providing high quality, due diligence research and independent, tailor made life science reports to pharmaceutical companies, competitive intelligence specialists, investment institutions and healthcare communication agencies. The research reports combine in-depth interviews with key opinion leaders, scientific analysis with market models to forecast the potential growth of key developmental products and technologies, identify marker drivers/resistors and identify unique selling features to guide product development
BlueSEQ is a specialized global consulting firm focused on Life Sciences, Digital Biology and Genomics markets. Their unique bland of Business Management , Technology Understanding and Strategy and Execution capabilities is what separates them form other consulting firms. The BlueSEQ Partners group offers customized consulting teams to help their clients gain access to relevant industry C-level expertise, which many of their consultants have achieved over many years' worth of successful management and scientific operations.
Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. It focuses on “omics”-level studies that seek to define the basis of interindividual variation in susceptibility for a disease, its prognosis or definition of clinical subsets, and response to therapy (pharmacogenomics). We are also interested in systems biology as it relates to interindividual variation, and research on new methodologies, informatics, and biostatistics, in the aforementioned areas. JPM is indexed in Science Citation Index Expanded, PubMed and Scopus. Its Scopus CiteScore is 3.59 in 2018.
Genes (ISSN 2073-4425) is an international, peer-reviewed open access journal which provides an advanced forum for studies related to genes, genetics and genomics. It publishes reviews, research articles, communications and technical notes. There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.
During the last decades, Cytogenetic and Genome Research has been the leading forum for original reports and reviews in human, animal, insect, and plant cytogenetics, including clinical, molecular, and comparative cytogenetics. With the advance of microarray and high throughput sequencing technologies, many of its papers have centered on genome research, including chromosome structure and function, genome evolution, human disease pathogenesis, cancer genomics, gene regulation and expression, epigenetics, and related areas.
The Journal of Precision Medicine is the world’s first print publication to discuss the many key global issues surrounding this rapidly evolving landscape. It does so by connecting both ends of the life science continuum – the compelling discoveries being realized in molecular research with the critical needs of the patient in the clinical setting. Providing a forum for the global Life Science community to share thought provoking and forward thinking opinion, The Journal of Precision Medicine will play an important role in advancing the progress already being made in this exciting field.
Cancers is an open access journal on oncology, with an Impact Factor of 5.326, ranking 44/222 (Q1) in the Oncology Category of Web of Science. More information about the journal can be accessed at: http://www.mdpi.com/journal/cancers. A first decision for peer reviewed manuscripts can be provided to authors in approximately 2-3 weeks after submission; acceptance to publication is undertaken within one week.
Part of Cambridge Healthtech Publishing, Diagnostics World News reports on cutting-edge content offerings in this era of precision medicine and new diagnostic tools. As molecular technologies let us peer into the pathways of disease, 21st century diagnostics are posed to change the way our illnesses are found, treated, and even defined. DiagnosticsWorldNews.com and the Diagnostics World News Newsletter provide authoritative news, views and insights on the vast landscape in the world of diagnostics.
Digital Biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices such as portables, wearables, implantables or digestibles. The data collected is typically used to explain, influence and/or predict health-related outcomes. Digital biomarkers also represent an opportunity to capture clinically meaningful, objective data. This innovative open access journal bridges the disciplines of computer science, engineering, biomedicine, regulatory science and informatics.
Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Launched in 1980, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new technologies and applications, investment growth, and career opportunities. GEN maintains unrivaled integrity, influence, and expertise that plays a pivotal role in driving the productivity and growth of the industry.
Diagnostics is an international, peer-reviewed scientific open access journal providing an advanced forum for medical diagnosis. It is published by MDPI online quarterly. Papers published in the Diagnostics will receive high publicity since the journal is freely available online. Diagnostics is covered by leading indexing services, including PubMed (PMC) and Emerging Sources Citation Index (ESCI – Web of Science).
Journal of Personalized Medicine is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., precision medicine, pharmacogenomics/proteomics, systems biology, ‘omics association analysis).
Journal of Clinical Medicine is an international scientific open access journal, providing a platform for advances in health care/clinical practices, the study of direct observation of patients and general medical research. This multi-disciplinary journal is aimed at a wide audience of medical researchers and healthcare professionals.
Bio-IT World – Weekly Update newsletter and News Bulletins cover the application of informatics, IT and computer science in biomedical research and drug discovery. As the life sciences become an increasingly quantitative discipline, Bio-IT World provides topical news coverage and analysis of cutting-edge technologies to handle the data deluge in petascale computing and the tools to deliver individualized medicine
Pharmalicensing is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.
Clocate.com is a leading international directory for worldwide conferences and exhibitions. Clocate.com is equipped with a unique and comprehensive search that helps you find easily any event in any category or location. Each event includes detailed information, like, description, dates, location, map, prices, link to the official event’s website and more… If you search for a conference or exhibition in areas such as Industry and manufacturing, Health and medicine, Technology and IT, Business and finance, sciences, education, services (banking, insurance, tourism, Hospitality and more), government, environment, life style and arts, you’ll find it in Clocate.com.
PharmaVOICE magazine reaches more than 46,000 BPA qualified subscribers and 60,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.